Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 714.00
Bid: 718.00
Ask: 720.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.279%)
Open: 722.00
High: 722.00
Low: 714.00
Prev. Close: 714.00
JCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Manager Changes

24 Jun 2024 16:00

RNS Number : 6493T
JPMorgan Claverhouse IT PLC
24 June 2024
 

 LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

 

24 June 2024

 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company')

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

 

 

Portfolio Manager Changes

 

The Board of JPMorgan Claverhouse Investment Trust plc (the "Company" or "JCH") has been notified that William Meadon is leaving J.P.Morgan Asset Management ("JPMorgan") in August 2024 after 28 years.

 

The Board has reviewed the Company's portfolio management arrangements with JPMorgan and is pleased to confirm that Callum Abbot, who has been a co-manager on the Company for the last six years, remains in this role and will be joined by Anthony Lynch and Katen Patel, as co-managers, with effect from 1 July 2024.

 

There is no change to the Company's investment objective or investment policy as a result of this change, which remain "to provide shareholders with a combination of capital and income growth from UK investments; investments will be made in a diversified portfolio consisting mostly of leading companies listed on the London Stock Exchange. The Company's portfolio consists of between 60 and 80 investments in which the Manager has high conviction."

 

Anthony and Katen both have experience of managing investment trusts and have demonstrated strong performance track records. They currently manage the JPM UK Equity Income Fund, which has outperformed its benchmark and is in the top quartile over 1 and 5 years and since inception in May 2017.

 

The Chairman of JCH, David Fletcher, commented:

 

"The Board would like to thank William for his significant contribution to the Company over the past 12 years and wish him every success in his future endeavours. We are pleased to welcome Anthony and Katen as co-managers of the Company's portfolio, alongside Callum. Both Anthony and Katen have strong track records of managing UK equity income portfolios and we have confidence that their addition to the investment team will benefit shareholders.

 

JCH is an AIC Dividend Hero*, delivering annual dividend growth for its shareholders every year since 1973. In particular, Anthony and Katen have experience investing in companies across the market capitalisation spectrum which we believe will assist the Company in continuing to fulfil its progressive dividend policy objective by focusing on high quality stocks with the ability to generate consistent and growing dividends. We look forward to working with the portfolio management team at this exciting time for investing in UK markets."

 

 

Portfolio Manager Biographies

 

Anthony Lynch, executive director, is a portfolio manager within JPMorgan's International Equity Group, based in London. He is a member of the UK Mid and Small Cap investment team, is a co-manager on The Mercantile Investment Trust plc and has additional responsibilities for equity income mandates investing in the listed UK market. An employee since 2009, Anthony joined the firm as a graduate trainee. He obtained a B.A. (Hons) in Economics from Durham University and is a CFA charterholder.

 

Callum Abbot, executive director, is a portfolio manager within the JPMorgan's International Equity Group, based in London. He is a member of the Core investment team and has been a co-manager on JPMorgan Claverhouse Investment Trust plc since 2018. An employee since 2012, Callum joined the firm as a graduate trainee. Callum obtained a BA (Hons) in Geography and Management at the University of Cambridge and is a CFA charterholder.

 

Katen Patel, executive director, is a portfolio manager within the JPMorgan's International Equity Group, based in London. He is a member of the UK Mid and Small Cap investment team, is a co-manager on JPMorgan UK Small Cap Growth & Income plc and has additional responsibilities for equity income mandates investing in the listed UK market. An employee since April 2013, he previously worked at HSBC Bank Plc in a European equity sales role. He obtained a BSc. in Management from the London School of Economics and Political Science and is a CFA charterholder.

 

 

For further information please contact:

 

JPMorgan Claverhouse Investment Trust plc Contact via the Company Secretary

David Fletcher

 

JPMorgan Funds Limited - Company Secretary +44 (0) 20 7742 4000

Anmol Dhillon

 

Deutsche Numis - Corporate Broker +44 (0) 20 7260 1426

Nathan Brown

 

 

* Awarded to investment companies that have increased their dividends each year for 20 years or more. In 2023, the Company raised its dividend for its 51st consecutive year.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVSRFISFIS
Date   Source Headline
28th Jun 202410:52 amRNSNet Asset Value(s)
27th Jun 202410:36 amRNSNet Asset Value(s)
26th Jun 20245:14 pmRNSTransaction in Own Shares
26th Jun 202410:34 amRNSNet Asset Value(s)
25th Jun 202411:04 amRNSNet Asset Value(s)
24th Jun 20244:00 pmRNSPortfolio Manager Changes
24th Jun 202411:29 amRNSGearing Announcement
24th Jun 202410:40 amRNSNet Asset Value(s)
21st Jun 202410:55 amRNSNet Asset Value(s)
20th Jun 202410:53 amRNSNet Asset Value(s)
19th Jun 202410:42 amRNSNet Asset Value(s)
18th Jun 202410:42 amRNSNet Asset Value(s)
17th Jun 20245:03 pmRNSTransaction in Own Shares
17th Jun 202411:16 amRNSGearing announcement
17th Jun 202410:39 amRNSNet Asset Value(s)
14th Jun 202411:01 amRNSNet Asset Value(s)
13th Jun 202410:37 amRNSNet Asset Value(s)
13th Jun 202410:13 amRNSDirector/PDMR Shareholding
13th Jun 20249:45 amRNSTen Largest Investments
12th Jun 20245:44 pmRNSTransaction in Own Shares
12th Jun 202410:26 amRNSNet Asset Value(s)
11th Jun 202410:29 amRNSNet Asset Value(s)
10th Jun 202411:54 amRNSGearing announcement
10th Jun 202411:11 amRNSNet Asset Value(s)
10th Jun 20247:00 amRNSKepler Trust Intelligence: New Research
7th Jun 202410:39 amRNSNet Asset Value(s)
6th Jun 202410:45 amRNSNet Asset Value(s)
5th Jun 202410:47 amRNSNet Asset Value(s)
4th Jun 202411:02 amRNSNet Asset Value(s)
3rd Jun 202412:02 pmRNSGearing Announcement
3rd Jun 202410:55 amRNSNet Asset Value(s)
31st May 202411:04 amRNSNet Asset Value(s)
30th May 202410:22 amRNSNet Asset Value(s)
29th May 202410:34 amRNSNet Asset Value(s)
28th May 202411:41 amRNSGearing Announcement
28th May 202411:08 amRNSNet Asset Value(s)
24th May 202410:36 amRNSNet Asset Value(s)
23rd May 202410:36 amRNSNet Asset Value(s)
22nd May 202411:08 amRNSNet Asset Value(s)
21st May 202411:38 amRNSNet Asset Value(s)
20th May 202411:56 amRNSGearing Announcement
20th May 202410:45 amRNSNet Asset Value(s)
17th May 202410:40 amRNSNet Asset Value(s)
16th May 202410:36 amRNSNet Asset Value(s)
15th May 202410:25 amRNSNet Asset Value(s)
14th May 202410:52 amRNSNet Asset Value(s)
13th May 202411:22 amRNSGearing announcement
13th May 202410:49 amRNSNet Asset Value(s)
13th May 20249:52 amRNSTen Largest Investments
10th May 202410:58 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.